SUMMARY In a prospective study of 156 female patients with Turner's syndrome who had survived infancy and been followed up for an average of 17 years there were 15 deaths. The expected mortality was 3*6. Sixteen of the patients had a congenital heart anomaly and five of the deaths occurred in this group. The 10 deaths in the remaining 140 were three times as many as expected. The reduction in life expectation was 12*5 years at age 1 year, 11 years at age 20, and 10 years at age 40. Deaths were due to a broad spectrum of diseases. In the sample as a whole there were eight deaths from diseases of the circulatory system. This number is significantly greater than expected, but four were due to congenital heart disease. When patients with congenital heart disease were omitted from the sample the mortality from circulatory disorders was not significantly increased. Within the category of circulatory disorders there were three deaths from dissection of the aorta, a number which is greatly in excess of the expected. Two of these patients had no previous evidence of heart disease.
Turner's syndrome is a condition in females which is characterised by short stature, gonadal dysgenesis, and a number of congenital morphological abnormalities. Because of the failure of gonadal development there is little or no sexual maturation at the age of puberty and a large proportion of patients are ascertained on this account. At an earlier age attention may be drawn to the condition because of failure to grow, congenital heart disease, and such morphological abnormalities as redundant folds of skin in the neck (pterygium coli), lymphangiectatic oedema, deformities of the ears, dystrophic nails, shortening of the metacarpals, cubitus valgus, ptosis, strabisumus, and pigmented naevi. Many of the congenital deformities were noted in infants by Ulrich in 1930,1 but the failure of normal sexual development at puberty was not emphasised until the condition was described in a series of young women by Turner in 1938.2 In most patients the syndrome can be attributed to partial or complete monosomy of the X chromosome.3 After early childhood the majority of patients have no recognisable gonadal tissue and the position of the ovaries is occupied by streaks of fibrous tissue. (Exceptionally, follicular cells may persist into adult life, and rare cases of fertility have been described.) Levels of plasma luteinising hormone (LH) and follicle-stimulating hormone (FSH) are elevated above the normal before and after puberty. Plasma oestrogens do not rise above prepubertal levels. Data obtained from the screening of consecutive newborn babies indicate that the incidence at birth is of the order of 3 per 10 000 female live births.
The infant mortality in Turner's syndrome is high. Robinson4 (table 6) .
Results
There were 15 deaths among the 156 patients observed over the 25 years of the study. The expected mortality in a female UK population of the same size and age structure would be 3-6. There is therefore a very significant increase in mortality (p<0O00001). The registered causes of death are shown in tables 7a and b. In the series as a whole 8 of the 15 deaths were due to diseases of the circulatory system compared with an expected mortality from this cause of 1 -2. Four of the deaths were in the 16 patients with congenital heart disease. In the remainder, the deaths from circulatory diseases are not significantly in excess of the expected (4 versus 1 -2; p<0-08). Three of the eight cardiovascular deaths were due to dissection of the aorta and two of these occurred in patients who had no previous evidence of valvular 
Discussion
The prevalence of Turner's syndrome after the age of 1 year is probably as low as 1 in 20 000-30 000 of the female population and this series could include the majority of patients with this disorder in Scotland and the North East of England. The mortality recorded in the sample is likely therefore to be representative of that experienced by Turner's syndrome patients in general after infancy. One third of deaths occurred in those with congenital heart disease but even among the remainder there was a threefold increase in mortality. It applied throughout the age range covered by the patients in the study, but as the majority of the patients had been ascertained either at birth or at puberty, very few had attained the age of 60 years and we were not able to make any observation on survival beyond that age. We have calculated the life expectation on the assumptions that mortality continues either at the same threefold increase in rate observed up to age 60, or that it then falls to the same level as that for all women. The threefold increase occurred in patients who had no obvious life threatening congenital abnormality, so we have no reason to believe that the increase in mortality will be any less after age 60. The life expectations based on the first assumption would seem to be the most likely therefore.
Most of the deaths were in patients with a 45,X karyotype but the same relative increase in mortality was observed in those with other karyotype abnormalities.
The incidence of severe congenital cardiovascular disease in Turner's syndrome is high. It 
